Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells
Charlotte Viant, Aurore Fenis, Gaëtan Chicanne, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale André, Caroline Denis, Caroline Soulas, et al.
Cell (2018) Vol. 175, Iss. 7, pp. 1731-1743.e13
Open Access | Times Cited: 1003
NK cells for cancer immunotherapy
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 965
Balancing natural killer cell activation through paired receptors
Ludovic Martinet, Mark J. Smyth
Nature reviews. Immunology (2015) Vol. 15, Iss. 4, pp. 243-254
Closed Access | Times Cited: 431
The polar regions in a 2°C warmer world
Eric Post, Richard B. Alley, Torben R. Christensen, et al.
Science Advances (2019) Vol. 5, Iss. 12
Open Access | Times Cited: 405
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Thorbald van Hall, Pascale André, Amir Horowitz, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 237
The NKG2A–HLA-E Axis as a Novel Checkpoint in the Tumor Microenvironment
Linda Borst, Sjoerd H. van der Burg, Thorbald van Hall
Clinical Cancer Research (2020) Vol. 26, Iss. 21, pp. 5549-5556
Open Access | Times Cited: 175
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Kyle B. Lupo, Sandro Matosevic
Cancers (2019) Vol. 11, Iss. 6, pp. 769-769
Open Access | Times Cited: 168
Novel targets for immune-checkpoint inhibition in cancer
Maxime Borgeaud, José Luís Sandoval, Michel Obéid, et al.
Cancer Treatment Reviews (2023) Vol. 120, pp. 102614-102614
Open Access | Times Cited: 55
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 46
The brave new world of innate lymphoid cells
Gérard Eberl, James P. Di Santo, Éric Vivier
Nature Immunology (2014) Vol. 16, Iss. 1, pp. 1-5
Closed Access | Times Cited: 152
Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned
Jeanette E. Boudreau, Katharine C. Hsu
Trends in Immunology (2018) Vol. 39, Iss. 3, pp. 222-239
Open Access | Times Cited: 152
NK cell education via nonclassical MHC and non-MHC ligands
Yuke He, Zhigang Tian
Cellular and Molecular Immunology (2016) Vol. 14, Iss. 4, pp. 321-330
Open Access | Times Cited: 149
NK Cell-Based Immunotherapies in Cancer
Min Hwa Shin, Jung‐Hee Kim, Siyoung A. Lim, et al.
Immune Network (2020) Vol. 20, Iss. 2
Open Access | Times Cited: 120
Remodeling of secretory lysosomes during education tunes functional potential in NK cells
Jodie P. Goodridge, Bénédikt Jacobs, Michelle Sætersmoen, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 113
Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia
Adeline Crinier, Pierre‐Yves Dumas, Bertrand Escalière, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 5, pp. 1290-1304
Open Access | Times Cited: 103
Natural Killer Cells: Tumor Surveillance and Signaling
Lizeth G. Meza Guzman, Narelle Keating, Sandra E. Nicholson
Cancers (2020) Vol. 12, Iss. 4, pp. 952-952
Open Access | Times Cited: 78
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity
P Bernard, Rebecca B. Delconte, Sonia Pastor, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004244-e004244
Open Access | Times Cited: 43
Genetically engineered hypoimmunogenic cell therapy
Akitsu Hotta, Sonja Schrepfer, András Nagy
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 960-979
Closed Access | Times Cited: 10
Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies
Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli
Cancers (2025) Vol. 17, Iss. 5, pp. 906-906
Open Access | Times Cited: 1
High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors
Antoine Marçais, Marie Marotel, Sophie Degouve, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 79
Shp1 function in myeloid cells
Clare L. Abram, Clifford A. Lowell
Journal of Leukocyte Biology (2017) Vol. 102, Iss. 3, pp. 657-675
Open Access | Times Cited: 77
SMAD4 promotes TGF-β–independent NK cell homeostasis and maturation and antitumor immunity
Youwei Wang, Jianhong Chu, Ping Yi, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 11, pp. 5123-5136
Open Access | Times Cited: 69
Newtonian cell interactions shape natural killer cell education
Jodie P. Goodridge, Björn Önfelt, Karl‐Johan Malmberg
Immunological Reviews (2015) Vol. 267, Iss. 1, pp. 197-213
Open Access | Times Cited: 68
H3K4me3 Demethylase Kdm5a Is Required for NK Cell Activation by Associating with p50 to Suppress SOCS1
Dezhi Zhao, Qian Zhang, Yiqi Liu, et al.
Cell Reports (2016) Vol. 15, Iss. 2, pp. 288-299
Open Access | Times Cited: 65
A hematopoietic cell–driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education
Ning Wu, Ming‐Chao Zhong, Romain Roncagalli, et al.
Nature Immunology (2016) Vol. 17, Iss. 4, pp. 387-396
Closed Access | Times Cited: 61
Page 1 - Next Page

Scroll to top